Microangiopathic hemolytic anemia
GPTKB entity
Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:abbreviation |
gptkb:MAHA
|
| gptkbp:affects |
red blood cells
|
| gptkbp:associatedWith |
gptkb:systemic_lupus_erythematosus
gptkb:thrombotic_microangiopathy gptkb:hemolytic_uremic_syndrome gptkb:malignant_hypertension thrombotic thrombocytopenic purpura disseminated intravascular coagulation |
| gptkbp:characterizedBy |
hemolysis
fragmentation of red blood cells |
| gptkbp:diagnosedBy |
blood smear
schistocytes |
| gptkbp:field |
hematology
|
| gptkbp:firstDescribed |
20th century
|
| https://www.w3.org/2000/01/rdf-schema#label |
Microangiopathic hemolytic anemia
|
| gptkbp:laboratoryFinding |
decreased haptoglobin
elevated lactate dehydrogenase increased indirect bilirubin |
| gptkbp:symptom |
gptkb:anemia
fatigue jaundice |
| gptkbp:treatment |
supportive care
treat underlying cause plasma exchange (in TTP) |
| gptkbp:bfsParent |
gptkb:Schistocytes
|
| gptkbp:bfsLayer |
8
|